Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Sebastien

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Journal of Biopharmaceutical Statistics|August 20, 2010
Comment on: Cheng, Chow, Burt, and Cosmatos (2008). Statistical assessment of QT/QTc prolongation based on maximum of correlated normal random variables. Journal of Biopharmaceutical Statistics 18(3):494-501Bernard Sebastien
Journal of Pharmacokinetics and Pharmacodynamics|May 6, 2023
Empirical bayes approach for dynamic bayesian borrowing for clinical trials in rare diseasesBernard Sebastien
Journal of Biopharmaceutical Statistics|August 17, 2021
Comparison of statistical methodologies used to estimate the treatment effect on time-to-event outcomes in observational studiesRana Jreich, Bernard Sebastien
Statistics in Medicine|October 28, 2020
Matching-adjusted indirect comparisons: Application to time-to-event dataJihane Aouni, Nadia Gaudel-Dedieu, Bernard Sebastien
Bone Marrow Transplantation|September 27, 2022
Development and validation of a predictive model to guide the use of plerixafor in pediatric populationBernard Sebastien, Peter Cheverton, Catherine Magnin, et al.
Biometrical Journal. Biometrische Zeitschrift|October 14, 2025
Sharp Bounds for Continuous-Valued Treatment Effects with Unobserved ConfoundersJean-Baptiste Baitairian, Bernard Sebastien, Rana Jreich, et al.
Clinical Pharmacology and Therapeutics|April 16, 2025
Innovations and Best Practices for Therapeutic Development in Pediatric Rare Diseases: A Model-Informed Drug Development PerspectiveRajesh Krishna, Satyendra Suryawanshi, Juliane Rascher, et al.
Journal of Biopharmaceutical Statistics|March 19, 2020
Design optimization for dose-finding trials: a reviewJihane Aouni, Jean Noel Bacro, Gwladys Toulemonde, et al.
Clinical Pharmacology and Therapeutics|August 15, 2024
Pediatric Rare Diseases Development in the Pharmaceutical Industry: An International Consortium for Innovation and Quality in Pharmaceutical Development, Clinical Pharmacology Leadership Group-Pediatrics Working Group, Rare Diseases Subteam Whitepaper Examining the Current Landscape and Recommendations for the FutureRajesh Krishna, Bernard Sebastien, Solange Corriol-Rohou, et al.
Journal of Biopharmaceutical Statistics|December 16, 2022
Use of pharmacodynamic modeling for Bayesian information borrowing in pediatric clinical trialsBernard Sebastien, S Y Amy Cheung, Solange Corriol-Rohou, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Biopharmaceutical Statistics|August 20, 2010
Comment on: Cheng, Chow, Burt, and Cosmatos (2008). Statistical assessment of QT/QTc prolongation based on maximum of correlated normal random variables. Journal of Biopharmaceutical Statistics 18(3):494-501Bernard Sebastien
Journal of Pharmacokinetics and Pharmacodynamics|May 6, 2023
Empirical bayes approach for dynamic bayesian borrowing for clinical trials in rare diseasesBernard Sebastien
Journal of Biopharmaceutical Statistics|August 17, 2021
Comparison of statistical methodologies used to estimate the treatment effect on time-to-event outcomes in observational studiesRana Jreich, Bernard Sebastien
Statistics in Medicine|October 28, 2020
Matching-adjusted indirect comparisons: Application to time-to-event dataJihane Aouni, Nadia Gaudel-Dedieu, Bernard Sebastien
Bone Marrow Transplantation|September 27, 2022
Development and validation of a predictive model to guide the use of plerixafor in pediatric populationBernard Sebastien, Peter Cheverton, Catherine Magnin, et al.
Biometrical Journal. Biometrische Zeitschrift|October 14, 2025
Sharp Bounds for Continuous-Valued Treatment Effects with Unobserved ConfoundersJean-Baptiste Baitairian, Bernard Sebastien, Rana Jreich, et al.
Clinical Pharmacology and Therapeutics|April 16, 2025
Innovations and Best Practices for Therapeutic Development in Pediatric Rare Diseases: A Model-Informed Drug Development PerspectiveRajesh Krishna, Satyendra Suryawanshi, Juliane Rascher, et al.
Journal of Biopharmaceutical Statistics|March 19, 2020
Design optimization for dose-finding trials: a reviewJihane Aouni, Jean Noel Bacro, Gwladys Toulemonde, et al.
Clinical Pharmacology and Therapeutics|August 15, 2024
Pediatric Rare Diseases Development in the Pharmaceutical Industry: An International Consortium for Innovation and Quality in Pharmaceutical Development, Clinical Pharmacology Leadership Group-Pediatrics Working Group, Rare Diseases Subteam Whitepaper Examining the Current Landscape and Recommendations for the FutureRajesh Krishna, Bernard Sebastien, Solange Corriol-Rohou, et al.
Journal of Biopharmaceutical Statistics|December 16, 2022
Use of pharmacodynamic modeling for Bayesian information borrowing in pediatric clinical trialsBernard Sebastien, S Y Amy Cheung, Solange Corriol-Rohou, et al.
Pageof 2